This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Hyperhidrosis
and you are
between 12 and 25
years old
-
The phase for this study is not defined.
Show me locations

The purpose

This is a single-center, prospective, open-label, outpatient pilot study evaluating the efficacy and tolerability of oxybutynin gel for axillary hyperhidrosis.

Provided treatments

  • Drug: Oxybutynin 3% gel

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02633371. The sponsor of the trial is University of Colorado, Denver and it is looking for 10 volunteers for the current phase.
Official trial title:
A Pilot Study Exploring the Efficacy and Safety of Topical Oxybutynin 3% Gel for Primary Focal Hyperhidrosis in Adolescents and Young Adults